Clinical Trials Logo

Clinical Trial Summary

The reported risk of nonreassuring fetal heart trace following neuraxial analgesia is 3-23%. This variability may be due to fluid and oxytocin management prior to and during the initiation of neuraxial analgesia. The study hypothesis is that decreasing the oxytocin infusion rate by 50 % prior to initiation of combined spinal epidural analgesia will cause a reduction in the incidence of adverse fetal heart rate changes.


Clinical Trial Description

Oxytocin is used in labor and delivery to increase the frequency of contractions and augment uterine contractile strength, thereby establishing a regular pattern of labor. However, the administration of exogenous oxytocin in the presence of an uncoordinated labor pattern confers a risk for an increase in uterine contraction frequency, resulting in inadequate relaxation periods. This leads to an increase in the basal tone of the uterus, which may lead to a tetanic contraction with the risk of decreased uteroplacental blood flow and fetal hypoxemia. Previous studies investigating low- versus high-dose oxytocin for induction or augmentation of labor have had conflicting results on the effect on fetal heart rate abnormalities. One of the limitations of these studies is that the labor analgesia was not standardized. The combination of low-dose combined spinal epidural analgesia and the high/low dose oxytocin have not been evaluated. One of the proposed mechanisms for nonreassuring fetal heart a tracing after initiation of analgesia is that the pain relief from neuraxial analgesia causes a decrease in catecholamine release by the sympathetic nervous system. The subsequent decrease in the circulating epinephrine concentration contributes to an increase in uterine tone, as epinephrine is a potent tocolytic agent. The increased tone, in turn, leads to a decrease in placental blood flow, and eventually fetal bradycardia. The primary outcome of this study is the incidence of non-reassuring fetal heart rate tracings within the first 60 minutes after the placement of combined spinal epidural analgesia ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03232918
Study type Interventional
Source University of Iowa
Contact Unyime Ituk
Phone 319-356-2633
Email unyime-ituk@uiowa.edu
Status Recruiting
Phase Phase 4
Start date February 20, 2019
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT06031142 - A Home Telemonitoring System for Wearable Fetal-ECG and EHG Acquisition During Pregnancy
Recruiting NCT05374135 - Effect of Dexamethasone on Fetal Heart Rate Variables In Case Of Imminent Preterm Labor
Completed NCT05369247 - Interval Versus Continuous Exercise During Pregnancy N/A
Recruiting NCT05958446 - Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women